Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?

This study is looking at whether a liver stiffness test (called elastography) can predict whether liver cancer will come back in people who had a liver tumor treated with a procedure that uses heat to destroy it (called radiofrequency ablation). Researchers hope this non-invasive test can help identify patients at higher risk of cancer returning. **You may be eligible if...** - You have chronic liver disease - You have been diagnosed with liver cancer (hepatocellular carcinoma) and are scheduled for radiofrequency ablation treatment - You have had or will have a liver stiffness test (Fibroscan or ARFI) - You are 18 years of age or older **You may NOT be eligible if...** - You are under 18 years old - You have a mixed or other type of liver tumor (not hepatocellular carcinoma) - You had a liver transplant or liver surgery for cancer in the past two years - Your liver disease is in advanced failure (Child-Pugh class C) - You have severe illness that makes participation unsafe Talk to your doctor to see if this trial is right for you.